SMO and gallbladder cancer: Of note, SMO inhibition by both cyclopamine and siRNA-mediated knockdown had no significant effect on GLI1 expression in gallbladder cancer cells, suggesting SMO-independent, aPKC-ι-mediated GLI1 activation [126].